Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group

O. Nielsen, Torsten; Leung, Samuel; L. Rimm, David; Dodson, Andrew; Ács, Balázs; Badve, Sunil; Denkert, Carsten; J. Ellis, Matthew; Fineberg, Susan; Flowers, Margaret; Kreipe, Hans; Lænkholm, Anne‐Vibeke; Pan, Hongchao; Penault‐Llorca, Frédérique; C. Polley, Mei‐Yin; Salgado, Roberto; E. Smith, Ian; Sugie, Tomoharu; M.S. Bartlett, John; M. McShane, Lisa; Dowsett, Mitch; F. Hayes, Daniel

doi:10.1093/jnci/djaa201

Public

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group

Published in JNCI Journal of the National Cancer Institute • Dec 9, 2020

Authors:

Torsten O. Nielsen

Samuel Leung

David L. Rimm

Abstract

Abstract Ki67 immunohistochemistry (IHC), commonly used as a proliferation marker in breast cancer, has limited value for treatment decisions due to questionable analytical validity. The International Ki67 in Breast Cancer Working Group (IKWG) consensus meeting, held in October 2019, assessed the cu...

Subject

Breast cancer

Oncology

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!